Anthony Ham

Anthony Ham is a seasoned professional in formulation development, currently serving as Senior Director at NOVAVAX INC since September 2020, after previously holding the position of Director within the same company. Prior to NOVAVAX, Anthony was the Director of Formulation at Prometic from July 2017 to August 2020, where responsibilities included directing formulation research and clinical trial materials manufacturing. Between February 2009 and July 2017, Anthony worked at ImQuest Biosciences as Director of Formulation Services, managing research programs for novel drug delivery systems. Earlier in career, Anthony served as a Post-Doctoral Fellow at Magee-Womens Research Institute and Foundation, focusing on targeted nanoparticle systems for anti-HIV treatments. Educationally, Anthony holds a Ph.D. in Biomedical Engineering from the University of Virginia and a B.S. in Chemical Engineering from the University of Illinois Urbana-Champaign.